Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
659.00    -6.00 (-0.90%)
Bid:
656.00
Ask:
659.00
Spread: 3.00 (0.457%)
Market Cap: £536.40m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Trading Update

7 Dec 2023 07:00

RNS Number : 9365V
Bloomsbury Publishing PLC
07 December 2023
 

BLOOMSBURY PUBLISHING PLC

("Bloomsbury" or "the Company")

Revenue comfortably ahead and profit materially ahead of expectations

Bloomsbury Publishing Plc (LSE: BMY), the leading independent publisher, is pleased to announce the following update on trading.

Revenue is now expected to be comfortably ahead and profit before taxation and highlighted items materially ahead of current market expectations* for the year ending 29 February 2024. This follows exceptionally strong trading in the Consumer division for a number of titles and particularly Sarah J. Maas' 15 titles. Bloomsbury has published all of Sarah J. Maas' books throughout the world and has seen excellent growth in the backlist. The Non-Consumer division continues to trade in line with current expectations.

Other important bestsellers in the Consumer division in the second half of the year to date include Ghosts, the companion book to the BBC television series, Poppy Cooks: The Actually Delicious Air Fryer Cookbook by Poppy O'Toole, Pub Kitchen by Tom Kerridge, The House of Doors by Tan Twan Eng in the US, the Harry Potter Wizarding Almanac, the official companion to J.K. Rowling's books, We're Going on a Sleigh Ride by Martha Mumford and Cherie Zamazing and the Waterstones Book of the Year 2023, Impossible Creatures by Katherine Rundell. Rundell's fantasy novel is the first children's book to win the prestigious award in six years.

Nigel Newton, Chief Executive, commented: "I am delighted to report a strong period of trading which is principally driven by the continued phenomenal demand for fantasy fiction. Bloomsbury has consistently built its success on the immense talent of our authors and the exceptional hard work of our teams who support them."

The Company will provide a further trading update on performance for the year ended 29 February 2024 in March 2024.

* The Board considers that the consensus market expectation for the year ending 29 February 2024 is currently revenue of £274.2 million and profit before taxation and highlighted items of £32.9 million.

For further information, please contact:

Bloomsbury Publishing Plc

Nigel Newton, Chief Executive

nigel.newton@bloomsbury.com

Penny Scott-Bayfield, Group Finance Director

penny.scott-bayfield@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus

bloomsbury@hudsonsandler.com

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward?looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward?looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDFSLRIIV
Date   Source Headline
17th Apr 202011:50 amRNSResult of Placing
17th Apr 20207:00 amRNSTrading and Dividend Update & Equity Placing
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20204:42 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSBloomsbury Acquires Zed Books' Assets
19th Mar 20207:00 amRNSPre-close Trading Update
5th Feb 20205:39 pmRNSDirector Declaration
10th Dec 201910:45 amRNSBloomsbury Acquires Oberon Books
2nd Dec 20197:00 amRNSBLOOMSBURY ENTERS DOMESTIC CHINESE MARKET
25th Nov 20195:15 pmRNSBlock Listing Six Monthly Return
29th Oct 20197:00 amRNSUnaudited Interim Results
21st Oct 20196:18 pmRNSHolding(s) in Company
16th Oct 20195:58 pmRNSHolding(s) in Company
12th Sep 20195:29 pmRNSHolding(s) in Company
5th Sep 20193:37 pmRNSHolding(s) in Company
22nd Aug 20197:00 amRNSDirector/PDMR Shareholding
17th Jul 20194:19 pmRNSResults of the 2019 Annual General Meeting
17th Jul 20197:00 amRNSTrading Update
18th Jun 20198:21 amRNSAnnual Financial Report
7th Jun 201911:34 amRNSHolding(s) in Company
7th Jun 20197:00 amRNSHolding(s) in Company
31st May 20193:11 pmRNSDirector/PDMR Shareholding
24th May 20193:21 pmRNSBlock listing Interim Review
23rd May 201912:30 pmRNSDirector/PDMR Shareholding
22nd May 20198:09 amRNSDividend Declaration
21st May 201912:47 pmRNSBoard Appointment
21st May 20197:00 amRNSAudited Preliminary Results
14th May 20193:19 pmRNSDirector/PDMR Shareholding
2nd May 20191:30 pmRNSHolding(s) in Company
4th Apr 20194:28 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSBloomsbury Publishing Plc - Trading Update
7th Jan 20197:00 amRNSBloomsbury Announces Two Digital Partnerships
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
20th Nov 20183:36 pmRNSBlock Listing Six Monthly Return
8th Nov 20189:00 amRNSBloomsbury's Sarah J. Maas tops bestseller lists
23rd Oct 20187:05 amRNSICAEW partners with Bloomsbury Professional
23rd Oct 20187:00 amRNSBloomsbury Interim Results
19th Sep 20187:00 amRNSBloomsbury to publish Authorised History of GCHQ
18th Sep 20185:29 pmRNSDirector/PDMR Shareholding
31st Jul 20185:25 pmRNSDirector/PDMR Shareholding
18th Jul 20183:00 pmRNSResult of AGM
18th Jul 20187:01 amRNSBloomsbury Partnership with YOOX NET-A-PORTER
18th Jul 20187:00 amRNSTrading Update
9th Jul 20187:00 amRNSBloomsbury Author Wins The Golden Man Booker Prize
6th Jul 20186:30 pmRNSHolding(s) in Company
18th Jun 201812:50 pmRNSAnnual Financial Report
7th Jun 201810:33 amRNSBloomsbury author wins major prize

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.